PLSE Stock Summary and Trading Ideas (Pulse Biosciences | NASDAQ:PLSE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

Pulse Biosciences trades on the NASDAQ stock market under the symbol PLSE.

As of April 1, 2026, PLSE stock price climbed to $23.03 with 260,867 million shares trading.

PLSE has a beta of 0.65, meaning it tends to be less sensitive to market movements. PLSE has a correlation of 0.03 to the broad based SPY ETF.

PLSE has a market cap of $1.56 billion. This is considered a Small Cap stock.

Last quarter Pulse Biosciences reported $264,000 in Revenue and -$.26 earnings per share. This beat revenue expectation by $14,000 and missed earnings estimates by -$.01.

In the last 3 years, PLSE traded as high as $26.30 and as low as $3.37.

The top ETF exchange traded funds that PLSE belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.

PLSE has outperformed the market in the last year with a price return of +43.1% while the SPY ETF gained +18.5%. PLSE has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +67.7% and +3.2%, respectively, while the SPY returned -3.6% and -2.1%, respectively.

PLSE support price is $20.59 and resistance is $22.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLSE shares will trade within this expected range on the day.